TA
VRTX icon

Teton Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Teton Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30,489
Closed -$2.66M – 450
2016
Q3 		$2.66M Hold
30,489
– – 0.23% 153
2016
Q2 		$2.62M Sell
30,489
-22
-0.1% -$1.9K 0.24% 140
2016
Q1 		$2.42M Sell
30,511
-17
-0.1% -$1.54K 0.22% 157
2015
Q4 		$3.84M Sell
30,528
-28,566
-48% -$3.45M 0.34% 90
2015
Q3 		$6.15M Sell
59,094
-1,016
-2% -$131K 0.47% 54
2015
Q2 		$7.42M Buy
60,110
+1
+0% +$126 0.51% 40
2015
Q1 		$7.09M Sell
60,109
-46,858
-44% -$5.61M 0.49% 49
2014
Q4 		$12.7M Buy
106,967
+46
+0% +$5.18K 0.83% 11
2014
Q3 		$12M Buy
106,921
+207
+0.2% +$19.7K 0.86% 9
2014
Q2 		$10.1M Sell
106,714
-5,731
-5% -$402K 0.67% 25
2014
Q1 		$7.95M Sell
112,445
-12,380
-10% -$980K 0.54% 45
2013
Q4 		$9.27M Buy
124,825
+25,164
+25% +$1.75M 0.65% 28
2013
Q3 		$7.56M Buy
99,661
+105
+0.1% +$8.36K 0.58% 43
2013
Q2 		$7.97M Buy
+99,556
New +$7.33M 0.7% 19

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Teton Advisors's VRTX Position: Q4 2016 in Review

Teton Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2016, closing a stake of 30,489 shares — an estimated $2.66M sold.

Teton Advisors first reported a position in VRTX in Q2 2013 and held it in 14 quarters. The position peaked at $12.7M in Q4 2014. 483 funds tracked by Wall St. Rank hold VRTX as of Q4 2016.

  • Teton Advisors reported no remaining Vertex Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Teton Advisors sold 30,489 Vertex Pharmaceuticals shares in Q4 2016, an estimated $2.66M.
  • Teton Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Teton Advisors's Vertex Pharmaceuticals position peaked at $12.7M in Q4 2014.
  • 483 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2016.

Based on Teton Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.